Prostate cancer (metastatic, castration resistant) - abiraterone (following cytoxic therapy): patient group, professional group and NHS organisation submission statements
Prostate cancer (metastatic, castration resistant) - abiraterone (following cytoxic therapy): Prostate Cancer Charity
Prostate cancer (metastatic, castration resistant) - abiraterone (following cytoxic therapy): Prostate Cancer Support Federation
Prostate cancer (metastatic, castration resistant) - abiraterone (following cytoxic therapy): Prostate Cancer Support Network
Prostate cancer (metastatic, castration resistant) - abiraterone (following cytoxic therapy): British Uro-Oncology Group
Prostate cancer (metastatic, castration resistant) - abiraterone (following cytoxic therapy): Royal College of Physicians on behalf of the NCRI/RCP/RCR/ACP/JCCO
Prostate cancer (metastatic, castration resistant) - abiraterone (following cytoxic therapy): NHS Bradford and Airedale
Prostate cancer (metastatic, castration resistant) - abiraterone (following cytoxic therapy): NHS Hertfordshire
This page was last updated: 10 February 2012
